Martine C.
- Country
- Belgium
- Department
- Department of Pediatrics
Research Overview
- Evaluation of Crinecerfont (NBI-74788) Efficacy and Safety in Pediatric Patients with Classic Congenital Adrenal Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial
- A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants with Congenital Adrenal Hyperplasia Including a Long-Term Extension
Data & Insights
Has run more than one trial at 4 of 37 partner sites.
Specializations
Pediatric Endocrinology
The investigator specializes in the treatment of Classic Congenital Adrenal Hyperplasia (CAH) in pediatric patients, focusing on innovative therapeutic approaches for managing this rare genetic condition.
- Adrenal disorders in children
- Steroid hormone regulation
- Pediatric endocrine disorders
Their research encompasses adrenal steroid level management and hormonal regulation in young patients.
Genetic Disorders
The investigator's work centers on understanding and treating inherited endocrine disorders, with particular emphasis on congenital conditions affecting hormone production.
- Genetic endocrine disorders
- Hormone synthesis pathways
- Developmental endocrinology
Their expertise extends to genetic factors influencing endocrine system development and function.
Therapeutic Development
The investigator focuses on evaluating novel therapeutic agents for endocrine disorders, particularly in the context of pediatric endocrine conditions.
- Novel therapeutic approaches
- Hormone replacement strategies
- Pediatric drug development
Their work includes assessment of new treatments for managing congenital endocrine disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.